Treatment & Recovery: Evidence-Based Approaches
Introduction
Biological Basis
Genetic predisposition accounts for 40-60% of the vulnerability to addiction, highlighting its nature as a medical condition.
Environmental Influence
Factors like early exposure, trauma, and socioeconomic conditions play critical roles in the development of SUD.
Recovery from addiction is possible. This module provides a comprehensive overview of evidence-based treatment approaches, from pharmacotherapy to behavioral interventions to mutual support programs. Understanding the full continuum of care enables healthcare professionals to guide patients toward appropriate resources and support their recovery journey.
Learning Objectives
By the end of this module, you will be able to:
- Describe the continuum of addiction treatment services
- Explain Medication-Assisted Treatment for different substances
- Compare CBT, motivational interviewing, and contingency management
- Discuss the evidence base for 12-step and other mutual support programs
- Apply principles of evidence-based prevention
The Treatment Continuum
Levels of Care
| Level | Setting | Intensity | Indication | |-------|---------|-----------|------------| | Early Intervention | Primary care, schools | Brief | At-risk use | | Outpatient | Office/clinic | 1-9 hrs/week | Mild-moderate SUD, stable | | Intensive Outpatient (IOP) | Clinic | 9-20 hrs/week | Moderate SUD, some stability | | Partial Hospitalization (PHP) | Hospital/clinic | 20+ hrs/week | Moderate-severe, need structure | | Residential | Treatment facility | 24/7 | Severe SUD, unstable environment | | Medically Managed Inpatient | Hospital | 24/7 medical | Medical withdrawal, comorbidities |
ASAM Criteria
The American Society of Addiction Medicine (ASAM) criteria guide level of care decisions based on six dimensions:
- Acute intoxication/withdrawal potential
- Biomedical conditions and complications
- Emotional, behavioral, or cognitive conditions
- Readiness to change
- Relapse, continued use, or continued problem potential
- Recovery/living environment
Medication-Assisted Treatment (MAT)
Alcohol Use Disorder
| Medication | Mechanism | Evidence | Notes | |------------|-----------|----------|-------| | Naltrexone | Opioid antagonist | Strong | Reduces craving, heavy drinking days | | Acamprosate | Glutamate modulation | Moderate | Maintains abstinence | | Disulfiram | Aldehyde dehydrogenase inhibitor | Moderate | Aversive reaction if drinking |
Naltrexone:
- Oral (daily) or injectable (monthly Vivitrol)
- Reduces reward from drinking
- Evidence strongest for reducing heavy drinking days
- Can use with goal of moderation or abstinence
Acamprosate:
- Three times daily dosing
- Best evidence for maintaining abstinence
- Works on glutamate/GABA balance
- Safe in liver disease
Disulfiram (Antabuse):
- Creates unpleasant reaction if alcohol consumed
- Nausea, flushing, headache, palpitations
- Requires high motivation, supervised administration
- Risk of severe reaction
Opioid Use Disorder
| Medication | Mechanism | Setting | Evidence | |------------|-----------|---------|----------| | Buprenorphine | Partial agonist | Office-based | Very strong | | Methadone | Full agonist | OTP only | Very strong | | Naltrexone | Antagonist | Any | Strong |
Buprenorphine (Suboxone, Subutex):
- Partial agonist at mu-receptor
- Ceiling effect limits overdose risk
- Office-based treatment possible
- Reduces mortality 50%+
Methadone:
- Full agonist, long half-life
- Requires daily dispensing at licensed clinic initially
- Most effective for high-dose opioid users
- Also reduces mortality 50%+
Naltrexone (Vivitrol):
- Monthly injection blocks opioid effects
- Requires completed detox (7-14 days opioid-free)
- Good for highly motivated patients
- Risk of overdose if relapse (lost tolerance)
Tobacco Use Disorder
| Treatment | Efficacy | Notes | |-----------|----------|-------| | Varenicline | Highest | Partial agonist at nicotinic receptor | | Combination NRT | High | Patch + short-acting (gum/lozenge) | | Single NRT | Moderate | Patch, gum, lozenge, inhaler, spray | | Bupropion | Moderate | Also treats depression |
Stimulant Use Disorder
No FDA-approved medications
Under investigation:
- Mirtazapine
- Bupropion + naltrexone
- N-acetylcysteine
- Topiramate
Behavioral treatments remain primary approach.
Behavioral Treatments
Cognitive Behavioral Therapy (CBT)
Core Principles:
- Thoughts, feelings, and behaviors are interconnected
- Maladaptive thought patterns drive substance use
- Skills can be learned to change patterns
- Focus on current problems, practical strategies
Key Components:
- Functional Analysis: Identify triggers, thoughts, feelings leading to use
- Skills Training: Coping with craving, refusal skills, problem-solving
- Cognitive Restructuring: Challenge distorted thinking
- Relapse Prevention: Identify high-risk situations, develop plans
Evidence: Strong evidence across substances; effects maintained post-treatment.
Motivational Interviewing (MI)
Core Principles:
- Ambivalence about change is normal
- Motivation is elicited, not imposed
- Patient is the expert on their own life
- Resistance is a signal to change approach
OARS Skills:
- Open questions: Encourage elaboration
- Affirmations: Recognize strengths
- Reflections: Demonstrate understanding
- Summaries: Link ideas together
The Spirit of MI:
- Partnership (collaboration, not hierarchy)
- Acceptance (autonomy, worth, empathy, affirmation)
- Compassion (prioritize patient welfare)
- Evocation (draw out patient's own motivations)
Evidence: Effective across substances; particularly useful for ambivalent patients.
Contingency Management (CM)
Core Principle: Provide tangible rewards for objectively verified positive behaviors (negative drug tests, treatment attendance).
Implementation:
- Frequent monitoring (e.g., twice-weekly urine tests)
- Immediate rewards for negative tests
- Escalating value for consecutive negatives
- Reset after positive test
Evidence: Strongest evidence for stimulant use disorders; effective across substances.
Challenges:
- Funding for incentives
- Administrative burden
- "Paying people not to use drugs" criticism
Community Reinforcement Approach (CRA)
Core Principle: Make a sober lifestyle more rewarding than substance use.
Components:
- Functional analysis
- Sobriety sampling (trial period of abstinence)
- Treatment plan with goals
- Social/recreational counseling
- Job-finding training
- Relationship counseling
- Relapse prevention
Often Combined With: Contingency management (CRA + Vouchers)
12-Step Programs
Overview
Alcoholics Anonymous (AA) founded 1935; model adapted for other substances:
- Narcotics Anonymous (NA)
- Cocaine Anonymous (CA)
- Gamblers Anonymous (GA)
- And many others
The 12 Steps (summarized):
- Admitted powerlessness over addiction
- Came to believe a higher power could restore sanity
- Made decision to turn will over to higher power
- Made a searching moral inventory
- Admitted wrongs to God, self, and another person 6-7. Became ready for and asked God to remove shortcomings 8-9. Made list of those harmed and made amends
- Continued personal inventory
- Sought through prayer/meditation to improve conscious contact
- Having had spiritual awakening, carry message to others
Evidence Base
Research Findings:
- AA attendance associated with better outcomes
- Effects mediated by increased self-efficacy, social support, coping
- Manualized Twelve-Step Facilitation (TSF) tested in Project MATCH
- TSF as effective as CBT and MET for alcohol
Cochrane Review (2020):
- AA/TSF produces higher rates of continuous abstinence
- Effects comparable or superior to other treatments for abstinence
Considerations
Strengths:
- Free and widely available
- Peer support
- Structured program
- Lifelong access
Limitations/Concerns:
- Spiritual component not for everyone
- "Powerlessness" concept criticized
- Abstinence-only focus
- Self-selection in studies
- May not suit all cultures
Alternatives to 12-Step
- SMART Recovery: CBT-based, secular
- Refuge Recovery/Recovery Dharma: Buddhist-based
- LifeRing: Secular, self-empowerment focus
- Women for Sobriety: Women-specific
- Moderation Management: For non-dependent problem drinkers
Evidence-Based Prevention
Prevention Levels Reviewed
| Level | Target | Examples | |-------|--------|----------| | Universal | Entire population | School programs, media campaigns, policy | | Selective | At-risk groups | Children of addicted parents, trauma survivors | | Indicated | Early symptoms | Brief interventions for risky use |
What Works in Prevention
Effective:
- Raising alcohol taxes
- Raising minimum drinking age
- Brief interventions in healthcare settings
- Family-based programs (Strengthening Families)
- Life skills training in schools
- Community-level interventions
Ineffective:
- Fear-based approaches ("Just Say No")
- Information-only education
- One-time assemblies
- DARE program (no effect on use)
SBIRT Model
Screening, Brief Intervention, and Referral to Treatment:
- Screening: Universal screening with validated tools (AUDIT, DAST)
- Brief Intervention: For at-risk users—feedback, advice, goal-setting
- Referral to Treatment: For those meeting SUD criteria
Evidence: Cost-effective, reduces risky drinking, increases treatment entry.
Recovery Support
Recovery Capital
Definition: The sum of resources necessary to initiate and sustain recovery.
Domains:
- Social: Relationships, support networks
- Physical: Health, safe housing, finances
- Human: Skills, education, employment
- Cultural: Values, beliefs, identity
- Community: Recovery community, resources
Recovery-Oriented Systems of Care
Modern approach recognizes:
- Recovery is a process, not an event
- Multiple pathways to recovery
- Services should be person-centered
- Peer support is valuable
- Recovery is supported by addressing social determinants
Peer Support Services
Peer Recovery Support Specialists:
- Individuals in recovery providing support to others
- Lived experience as qualification
- Bridge between treatment and community
- Evidence for improved outcomes
Case Study: Treatment Planning
Deepak, 42, presents for treatment of alcohol use disorder. He drinks 8-10 drinks daily, has tried to quit multiple times, and experienced withdrawal seizures once in the past. He is employed, married, and his wife is supportive. He has mild liver enzyme elevation but no cirrhosis. He is ambivalent about complete abstinence.
Discussion Questions:
- 4What level of care would you recommend for initial treatment?
- 5Which medications would you consider?
- 6What behavioral approaches would be appropriate given his ambivalence?
- 7Would you recommend 12-step or alternative mutual support?
- 8How would you involve his wife?
Key Takeaways
- Treatment exists on a continuum from brief intervention to residential care
- MAT is first-line for opioid and alcohol use disorders, reducing mortality significantly
- CBT, MI, and CM are evidence-based behavioral treatments with different strengths
- 12-step programs have evidence for effectiveness; alternatives exist for those who prefer
- Fear-based prevention doesn't work; policy changes and skills training do
- Recovery is supported by building recovery capital across multiple domains
- Peer support services are increasingly recognized as valuable
Next Module: Ethics, Law & The Future of Addiction Treatment →
Learning Resources
Study Assistant
External links
Hi! I'm your learning assistant. Use the external links below to explore "Treatment & Recovery: Evidence-Based Approaches" safely in ChatGPT or Claude.
Need Help?
Join our expert-led forum to discuss case studies with fellow clinicians.
Study Assistant
External links
Hi! I'm your learning assistant. Use the external links below to explore "Treatment & Recovery: Evidence-Based Approaches" safely in ChatGPT or Claude.
Need Help?
Join our expert-led forum to discuss case studies with fellow clinicians.
